Hazel M. Aker Intends to Retire as General Counsel of Oncternal Therapeutics, Inc., Effective August 15, 2020
July 31, 2020 at 04:33 pm EDT
On July 28, 2020, Hazel M. Aker notified Oncternal Therapeutics, Inc. that she intends to retire effective August 15, 2020 and will resign from her position as the Company's General Counsel. In connection with her retirement, the Company expects to enter into a consulting agreement with Ms. Aker providing for an hourly retainer and continued vesting of her stock awards.